Content deleted Content added
No edit summary |
The chemistds (talk | contribs) added CSID |
||
Line 28: | Line 28: | ||
| ATC_suffix = |
| ATC_suffix = |
||
| PubChem = 86273676 |
| PubChem = 86273676 |
||
| ChemSpiderID |
| ChemSpiderID = 48060412 |
||
| smiles = CCCCCN1N=C(C(=O)NC(C)(C)C2=CC=CC=C2)C2=CC=CC=C12 |
| smiles = CCCCCN1N=C(C(=O)NC(C)(C)C2=CC=CC=C2)C2=CC=CC=C12 |
||
| StdInChI = 1S/C22H27N3O/c1-4-5-11-16-25-19-15-10-9-14-18(19)20(24-25)21(26)23-22(2,3)17-12-7-6-8-13-17/h6-10,12-15H,4-5,11,16H2,1-3H3,(H,23,26) |
| StdInChI = 1S/C22H27N3O/c1-4-5-11-16-25-19-15-10-9-14-18(19)20(24-25)21(26)23-22(2,3)17-12-7-6-8-13-17/h6-10,12-15H,4-5,11,16H2,1-3H3,(H,23,26) |
Revision as of 17:11, 19 December 2016
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C22H27N3O |
Molar mass | 349.5 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
CUMYL-PINACA (also known as SGT-24) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-PINACA acts as a potent agonist for the cannabinoid receptors, with approximately 3x selectivity for CB1, having an EC50 of 0.15nM for human CB1 receptors and 0.41nM for human CB2 receptors.[1]
Legal status
Sweden's public health agency suggested to classify CUMYL-PINACA as hazardous substance on November 10, 2014.[2]
See also
References
- ^ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.